U.S., Dec. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07295392) titled 'Is There Any Prognostic Value of Serum Uromodulin in Sepsis Induced AKI , as a Tool Helping us to Predict the Clinical Outcomes in Adult Patient With Sepsis Induced AKI.' on Dec. 08.
Brief Summary: To determine whether baseline (day 0; day of diagnosis),day 7 and on discharge serum uromodulin levels help predict clinical outcomes in adult patients with sepsis induced AKI.
Study Start Date: March 10, 2026
Study Type: OBSERVATIONAL
Condition:
Sepsis Induced Acute Kidney Injury
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assiut University
Information provided by (Responsible Party): Shaymaa Ibrahim Mohammed Hassan, Assiut Un...